Showing results (141-150 of 171) with videos related to

Sort By:
Pageof 18
International Journal of Clinical Oncology|July 16, 2020
Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective studyShintaro Nakano, Satoshi Yuki, Yasuyuki Kawamoto, et al.
Anticancer Research|November 14, 2013
Non-randomized comparison between irinotecan plus mitomycin C and irinotecan alone in patients with advanced gastric cancer refractory to fluoropyrimidine and platinumAkira Ueda, Ayumu Hosokawa, Kohei Ogawa, et al.
Future Oncology (London, England)|May 8, 2025
A multicenter, prospective, observational study of nivolumab readministration for advanced gastric cancer (NIVO RETURNS)Hiroyuki Kodama, Yukiya Narita, Michio Nakamura, et al.
Journal of Clinical Medicine|February 10, 2024
The Efficacy and Safety of Nivolumab Plus mFOLFOX6 in Gastric Cancer with Severe Peritoneal MetastasisYurika Nakayama, Takayuki Ando, Naoki Takahashi, et al.
Cancers|March 13, 2024
CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric CancerAkira Ueda, Satoshi Yuki, Takayuki Ando, et al.
Future Oncology (London, England)|June 6, 2025
A multicenter Phase II study of mFOLFOX6 plus nivolumab for gastric cancer with severe peritoneal metastases: WJOG16322GMunehiro Wakabayashi, Toshiki Masuishi, Takatsugu Ogata, et al.
Scientific Reports|December 10, 2025
A mixed methods study comparing video based and paper based diagnostic error education for medical studentsTaiju Miyagami, Kosuke Ishizuka, Seiko Furusaka-Kushiro, et al.
Journal of Gastroenterology|March 19, 2024
Severe induction of aberrant DNA methylation by nodular gastritis in adultsAkiko Sasaki, Hideyuki Takeshima, Satoshi Yamashita, et al.
BMC Cancer|December 16, 2022
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE studyMichio Nakamura, Atsushi Ishiguro, Masayoshi Dazai, et al.
Eclinicalmedicine|February 9, 2026
Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in JapanKenro Hirata, Yasuo Hamamoto, Hirokazu Shoji, et al.
Pageof 18